We are live on ! Find out more
NVO

Novo Nordisk
NVO

644 hedge funds and large institutions have $9.5B invested in Novo Nordisk in 2020 Q1 according to their latest regulatory filings, with 71 funds opening new positions, 165 increasing their positions, 281 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more funds holding in top 10

Funds holding in top 10: 13 → 21 (+8)

18% more call options, than puts

Call options by funds: $30.8M | Put options by funds: $26.1M

16% more first-time investments, than exits

New positions opened: 71 | Existing positions closed: 61

1% more funds holding

Funds holding: 640 → 644 (+4)

4% less capital invested

Capital invested by funds: $9.9B → $9.5B (-$397M)

1.41% less ownership

Funds ownership: 18.37% → 16.96% (-1.4%)

41% less repeat investments, than reductions

Existing positions increased: 165 | Existing positions reduced: 281

Holders
644
Holders Change
+4
Holders Change %
+0.63%
% of All Funds
14.19%
Holding in Top 10
21
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+61.54%
% of All Funds
0.46%
New
71
Increased
165
Reduced
281
Closed
61
Calls
$30.8M
Puts
$26.1M
Net Calls
+$4.79M
Net Calls Change
-$59.9M

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$97.9M
2
Jane Street
Jane Street
New York
+$29.1M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$21.2M
4
OMC
Old Mission Capital
Illinois
+$17.3M
5
Capital International Investors
Capital International Investors
California
+$16.8M

Top Sellers

1
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
-$317M
2
SGA
Sustainable Growth Advisers
Connecticut
-$135M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$62.2M
4
AAMU
Amundi Asset Management US
Massachusetts
-$56.6M
5
Bank of America
Bank of America
North Carolina
-$54.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$1.68B +$97.9M +3,286,400 +6%
Loomis, Sayles & Company
2
Loomis, Sayles & Company
Massachusetts
$989M -$317M -10,653,652 -24%
Fisher Asset Management
3
Fisher Asset Management
Washington
$923M +$14.1M +473,726 +2%
Bank of America
4
Bank of America
North Carolina
$631M -$54.4M -1,826,302 -8%
F
5
Folketrygdfondet
Norway
$346M +$122K +4,088 +0%
State Street
6
State Street
Massachusetts
$259M -$8.16M -274,026 -3%
Fayez Sarofim & Co
7
Fayez Sarofim & Co
Texas
$254M -$10.7M -359,328 -4%
Arrowstreet Capital
8
Arrowstreet Capital
Massachusetts
$234M -$6.48M -217,468 -3%
State Farm Mutual Automobile Insurance
9
State Farm Mutual Automobile Insurance
Illinois
$220M -$21.3M -714,832 -9%
EHC
10
Everett Harris & Co
California
$190M +$2.13M +71,390 +1%
BlackRock
11
BlackRock
New York
$142M -$23.4M -784,910 -14%
Northern Trust
12
Northern Trust
Illinois
$135M -$3.93M -132,122 -3%
PPA
13
Parametric Portfolio Associates
Washington
$131M -$4.32M -145,162 -3%
Capital International Investors
14
Capital International Investors
California
$131M +$16.8M +563,040 +15%
ClearBridge Investments
15
ClearBridge Investments
New York
$130M +$8.75M +293,828 +7%
AllianceBernstein
16
AllianceBernstein
Tennessee
$111M -$19.8M -664,332 -15%
AG
17
Aperio Group
California
$92.9M +$8.34M +280,070 +10%
SRIM
18
Saratoga Research & Investment Management
California
$91.5M -$686K -23,026 -0.8%
Natixis Advisors
19
Natixis Advisors
Massachusetts
$91.1M -$11.8M -397,692 -12%
EVM
20
Eaton Vance Management
Massachusetts
$89.2M -$2.51M -84,254 -3%
Wells Fargo
21
Wells Fargo
California
$86.9M +$1.25M +41,934 +1%
Ameriprise
22
Ameriprise
Minnesota
$82.5M -$31.7M -1,062,976 -28%
Royal Bank of Canada
23
Royal Bank of Canada
Ontario, Canada
$82.5M -$6.51M -218,782 -7%
RJA
24
Raymond James & Associates
Florida
$79.2M +$6.12M +205,698 +8%
Boston Partners
25
Boston Partners
Massachusetts
$75.2M -$49.9M -1,674,248 -40%
1
2 3 4 5

NVO Hedge Fund Activity: Q1 2020 in Review

644 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q1 2020, worth a combined $9.5B — down 4% from $9.9B a quarter earlier.

Buyers outnumbered sellers: 71 funds opened new NVO positions and 61 closed out — a net gain of 10 holders — while 165 added to existing stakes and 281 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $97.9M. The largest seller was Loomis, Sayles & Company, cutting an estimated $317M.

  • 644 institutional investors held Novo Nordisk (NVO) as of Q1 2020, up from 640 in Q4 2019.
  • Funds reported $9.5B of Novo Nordisk stock for Q1 2020, down 4% quarter-over-quarter.
  • 71 funds opened new Novo Nordisk positions in Q1 2020 and 61 closed out, a net change of +10 holders.
  • The largest Novo Nordisk buyer in Q1 2020 was Renaissance Technologies, an estimated $97.9M added.
  • The largest Novo Nordisk seller in Q1 2020 was Loomis, Sayles & Company, an estimated $317M sold.

Based on aggregated 13F filings for Q1 2020.